← SynDRA
PD-168393
SynDRA canonical compound SYN1949363 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | EGFR | ERBB2 | SRC |
| Mechanism of action | EGFR inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- pd 168393
- PD168393
- UNII-3R996Y9T0I
- 4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline
- n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}prop-2-enamide
- N-[4-(3-bromoanilino)quinazolin-6-yl]prop-2-enamide
- CHEMBL285063
- 3R996Y9T0I
- C17H13BrN4O
- N-[4-(3-Bromo-phenylamino)-quinazolin-6-yl]-acrylamide
- 2-Propenamide, N-(4-((3-bromophenyl)amino)-6-quinazolinyl)-
- 2-Propenamide, N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-
- nchembio866-comp2
- N-(4-((3-bromophenyl)amino)quinazolin-6-yl)acrylamide
Look up PD-168393 in the interactive SynDRA portal →